Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Arch Psychiatry Clin Neurosci ; 269(8): 931-940, 2019 Dec.
Article in English | MEDLINE | ID: mdl-30539230

ABSTRACT

Obsessive-compulsive symptoms (OCS) in patients with schizophrenia are a common co-occurring condition, often associated with additional impairments. A subgroup of these patients develops OCS during treatment with second-generation antipsychotics (SGAs), most importantly clozapine and olanzapine. So far, little is known about possible neural mechanism of these SGAs, which seem to aggravate or induce OCS. To investigate the role of SGA treatment on neural activation and connectivity during emotional processing, patients were stratified according to their monotherapy into two groups (group I: clozapine or olanzapine, n = 20; group II: amisulpride or aripiprazole, n = 20). We used an fMRI approach, applying an implicit emotion recognition task. Group comparisons showed significantly higher frequency and severity of comorbid OCS in group I than group II. Task specific activation was attenuated in group I in the left amygdala. Furthermore, functional connectivity from left amygdala to right ventral striatum was reduced in group I. Reduced amygdala activation was associated with OCS severity. Recent literature suggests an involvement of an amygdala-cortico-striatal network in the pathogenesis of obsessive-compulsive disorder. The observed differential activation and connectivity pattern of the amygdala might thus indicate a neural mechanism for the development of SGA-associated OCS in patients with schizophrenia. Further neurobiological research and interventional studies are needed for causal inferences.


Subject(s)
Amygdala/drug effects , Antipsychotic Agents/therapeutic use , Clozapine/therapeutic use , Olanzapine/therapeutic use , Schizophrenia/drug therapy , Adult , Amygdala/diagnostic imaging , Amygdala/pathology , Amygdala/physiopathology , Carrier Proteins , Female , Functional Neuroimaging , Humans , Male , Neural Pathways/drug effects , Neural Pathways/pathology , Neural Pathways/physiopathology , Saccharomyces cerevisiae Proteins , Schizophrenia/diagnostic imaging , Schizophrenia/pathology , Schizophrenia/physiopathology
2.
Environ Sci Technol ; 41(14): 5149-53, 2007 Jul 15.
Article in English | MEDLINE | ID: mdl-17711237

ABSTRACT

Nanocrystalline titanium dioxide (nanoTiO2) has been reported to generate reactive oxygen species (ROS) under UV illumination. In our studies, changes in mechanical properties of human skin fibroblasts, exposed to the oxidative stress induced in the presence of nanoTiO2 and UV light, were studied using atomic force microscopy (AFM). The exposure of cells to the action of ROS was performed at low TiO2 concentration (4 microg/mL) and under illumination with low-intensity UVA (8 and 20 mW/cm2) or UVC (0.1 mW/ cm2). AFM measurements of the cell stiffness were carried out immediately after exposure of cells to the oxidative stress. The data suggest that under illumination with low-intensity UVA nanoTiO2 generates ROS, which, in turn, damage cellular and subcellular structures. This process was detected by AFM as a marked drop in the cellular stiffness of ca. 30-75%, which occurred rapidly, in the time frame of 1 min. The photo-oxidative stress inducing the decrease of cell stiffness was cancelled in the presence of a well-established antioxidant, beta-carotene. The results highlight the sensitivity of AFM to detect early changes in mechanical properties of cells exposed to oxidative stress.


Subject(s)
Metal Nanoparticles , Titanium/chemistry , Ultraviolet Rays , Humans , Microscopy, Atomic Force , Reactive Oxygen Species
SELECTION OF CITATIONS
SEARCH DETAIL
...